Tissue Engineered, Hydrogel-Based Endothelial Progenitor Cell Therapy Robustly Revascularizes Ischemic Myocardium and Preserves Ventricular Function

OBJECTIVE: Cell based angiogenic therapy for ischemic heart failure has had limited clinical impact, likely related to very low cell retention (<1%) and dispersion. We developed a novel, tissue engineered, hydrogel based cell delivery strategy to overcome these limitations and provide prolonged r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Atluri, Pavan, Miller, Jordan S, Emery, Robert J, Hung, George, Trubelja, Alen, Cohen, Jeffrey E, Lloyd, Kelsey, Han, Jason, Gaffey, Ann C, MacArthur, John W, Chen, Christopher S, Woo, Y Joseph
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155940/
https://ncbi.nlm.nih.gov/pubmed/25129603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2014.06.038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars